338 related articles for article (PubMed ID: 36746113)
21. A review of cardiovascular effects and underlying mechanisms of legacy and emerging per- and polyfluoroalkyl substances (PFAS).
Wen ZJ; Wei YJ; Zhang YF; Zhang YF
Arch Toxicol; 2023 May; 97(5):1195-1245. PubMed ID: 36947184
[TBL] [Abstract][Full Text] [Related]
22. Nontargeted identification of per- and polyfluoroalkyl substances in human follicular fluid and their blood-follicle transfer.
Kang Q; Gao F; Zhang X; Wang L; Liu J; Fu M; Zhang S; Wan Y; Shen H; Hu J
Environ Int; 2020 Jun; 139():105686. PubMed ID: 32278886
[TBL] [Abstract][Full Text] [Related]
23. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
[TBL] [Abstract][Full Text] [Related]
24. Associations between Mixture of Perfluoroalkyl Substances and Lipid Profile in a Highly Exposed Adult Community in the Veneto Region.
Batzella E; Zare Jeddi M; Pitter G; Russo F; Fletcher T; Canova C
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231722
[TBL] [Abstract][Full Text] [Related]
25. Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years.
Dunder L; Lind PM; Salihovic S; Stubleski J; Kärrman A; Lind L
Environ Res; 2022 Aug; 211():112903. PubMed ID: 35231461
[TBL] [Abstract][Full Text] [Related]
26. Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region.
Canova C; Barbieri G; Zare Jeddi M; Gion M; Fabricio A; Daprà F; Russo F; Fletcher T; Pitter G
Environ Int; 2020 Dec; 145():106117. PubMed ID: 32971418
[TBL] [Abstract][Full Text] [Related]
27. Demographic, life-style and physiological determinants of serum per- and polyfluoroalkyl substance (PFAS) concentrations in a national cross-sectional survey of Swedish adolescents.
Nyström J; Benskin JP; Plassmann M; Sandblom O; Glynn A; Lampa E; Gyllenhammar I; Moraeus L; Lignell S
Environ Res; 2022 May; 208():112674. PubMed ID: 34998808
[TBL] [Abstract][Full Text] [Related]
28. Occurrence of legacy and alternative per- and polyfluoroalkyl substances in serum from high exposure population and their disrupting effects on serum lipids and thyroid function.
Liu J; Song L; Zhan J; Zhong Y; Shi Z
Sci Total Environ; 2023 Jun; 878():162988. PubMed ID: 36958558
[TBL] [Abstract][Full Text] [Related]
29. Early-life associations between per- and polyfluoroalkyl substances and serum lipids in a longitudinal birth cohort.
Blomberg AJ; Shih YH; Messerlian C; Jørgensen LH; Weihe P; Grandjean P
Environ Res; 2021 Sep; 200():111400. PubMed ID: 34081971
[TBL] [Abstract][Full Text] [Related]
30. Emerging and legacy PFAS and cytokine homeostasis in women of childbearing age.
Nian M; Zhou W; Feng Y; Wang Y; Chen Q; Zhang J
Sci Rep; 2022 Apr; 12(1):6517. PubMed ID: 35444213
[TBL] [Abstract][Full Text] [Related]
31. Joint effects of per- and polyfluoroalkyl substance alternatives and heavy metals on renal health: A community-based population study in China.
Liang LX; Dong P; Zhou Y; Zhang L; Qian Z; Geiger SD; Bingheim E; Tang X; Wu Y; Lv J; Lin LZ; Zeeshan M; Zeng XW; Feng W; Dong GH
Environ Res; 2023 Feb; 219():115057. PubMed ID: 36529335
[TBL] [Abstract][Full Text] [Related]
32. Occurrences of legacy and emerging per- and polyfluoroalkyl substances in human milk in China: Results of the third National Human Milk Survey (2017-2020).
Han F; Wang Y; Li J; Lyu B; Liu J; Zhang J; Zhao Y; Wu Y
J Hazard Mater; 2023 Feb; 443(Pt A):130163. PubMed ID: 36272370
[TBL] [Abstract][Full Text] [Related]
33. Per-/polyfluoroalkyl substance concentrations in human serum and their associations with liver cancer.
Cao L; Guo Y; Chen Y; Hong J; Wu J; Hangbiao J
Chemosphere; 2022 Jun; 296():134083. PubMed ID: 35216980
[TBL] [Abstract][Full Text] [Related]
34. Associations of per- and polyfluoroalkyl substances and their alternatives with bone mineral density levels and osteoporosis prevalence: A community-based population study in Guangzhou, Southern China.
Fan S; Wu Y; Bloom MS; Lv J; Chen L; Wang W; Li Z; Jiang Q; Bu L; Shi J; Shi T; Zeng X; Zhang L; Zhang Z; Yang B; Dong G; Feng W
Sci Total Environ; 2023 Mar; 862():160617. PubMed ID: 36462653
[TBL] [Abstract][Full Text] [Related]
35. Exposure to Per- and Polyfluoroalkyl Substances and Mortality in U.S. Adults: A Population-Based Cohort Study.
Wen X; Wang M; Xu X; Li T
Environ Health Perspect; 2022 Jun; 130(6):67007. PubMed ID: 35731224
[TBL] [Abstract][Full Text] [Related]
36. Exposure to per- and polyfluoroalkyl substances (PFASs) in serum versus semen and their association with male reproductive hormones.
Cui Q; Pan Y; Wang J; Liu H; Yao B; Dai J
Environ Pollut; 2020 Nov; 266(Pt 2):115330. PubMed ID: 32781340
[TBL] [Abstract][Full Text] [Related]
37. Environmental exposure to legacy and emerging per- and polyfluoroalkyl substances and endometriosis in women of childbearing age.
Ao J; Zhang R; Huo X; Zhu W; Zhang J
Sci Total Environ; 2024 Jan; 907():167838. PubMed ID: 37839491
[TBL] [Abstract][Full Text] [Related]
38. Associations of prenatal PFAS exposure and early childhood neurodevelopment: Evidence from the Shanghai Maternal-Child Pairs Cohort.
Zhou Y; Li Q; Wang P; Li J; Zhao W; Zhang L; Wang H; Cheng Y; Shi H; Li J; Zhang Y
Environ Int; 2023 Mar; 173():107850. PubMed ID: 36857906
[TBL] [Abstract][Full Text] [Related]
39. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
[TBL] [Abstract][Full Text] [Related]
40. An investigation of 3M Cordova, IL production worker's per- and polyfluoroalkyl substances biomonitoring results and mortality experience.
Andres KL; Olsen GW; Krisko RM; Nunnally MC; Boeding RR; Leniek KL; Taiwo OA
Int J Hyg Environ Health; 2024 Mar; 256():114321. PubMed ID: 38244249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
